Momenta Pharmaceuticals, Inc. Reports $1.26 Earnings Per Share for the Second Quarter of 2011

CAMBRIDGE, Mass., Aug. 4, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today reported its financial results for the quarter ended June 30, 2011.

Back to news